Chemodynamic therapy (CDT) is an
emerging tumor treatment; however,
it is hindered by insufficient endogenous hydrogen peroxide (H2O2) and high glutathione (GSH) concentrations in
the tumor microenvironment (TME). Furthermore, CDT has limited therapeutic
efficacy as a monotherapy. To overcome these limitations, in this
study, a nanoplatform is designed and constructed from Cu-doped mesoporous
Prussian blue (CMPB)-encapsulated glucose oxidase (GOx) with a coating
of hyaluronic acid (HA) modified with a nitric oxide donor (HN). In
the proposed GOx@CMPB-HN nanoparticles, the dopant Cu2+ ions are crucial to combining and mutually promoting multiple therapeutic
approaches, namely, CDT, photothermal therapy (PTT), and starvation
therapy. The dopant Cu2+ ions in CMPB protect against reactive
oxygen species to deplete the intracellular GSH in the TME. Additionally,
the byproduct Cu+ ions act as a substrate for a Fenton-like
reaction that activates CDT. Moreover, H2O2,
which is another important substrate, is produced in large quantities
through intracellular glucose depletion caused by the nanoparticle-loaded
GOx, and the gluconic acid produced in this reaction further enhances
the TME acidity and creates a better catalytic environment for CDT.
In addition, Cu2+ doping greatly improves the mesoporous
Prussian blue (MPB) photothermal conversion performance, and the resultant
increase in temperature accelerates CDT catalysis. Finally, the HN
coating enables the nanoparticles to actively target CD44 receptors
in cancer cells and also enhances vascular permeability. Therefore,
this coating has multiple effects, such as facilitating enhanced permeability
and retention and deep laser penetration. In vitro and in vivo experiments
demonstrate that the proposed GOx@CMPB-HN nanoplatform significantly
inhibits tumor growth with the help of in situ enhanced synergistic
therapies based on the properties of the TME. The developed nanoplatform
has the potential to be applied to cancer treatment and introduces
new avenues for tumor treatment research.